encyclopedia of medical concepts
ψ
Naphthyridines
More information
in Books
or on
Definition
:
Examples
Nalidixic Acid
Substance
CAS Registry & name
Categories
Source
Drugs
*
3-
(4-
fluoro-
2-
methoxy-
benzyl)-
7-
hydroxy-
8,9-
dihydro-
3H,7H-
pyrrolo(2,3-
c)(1,7)naphthyridin-
6-
one
0
*Naphthyridines
HIV Integrase Inhibitors.
Xenobiotica. 2012 Jan;42(1):57-74.
NM13 compound
0
*Naphthyridines
Anti-HIV Agents.
ChemMedChem. 2011 Jul 4;6(7):1249-57
3-
(4-
(3-
chlorophenyl)-
1-
ethyl-
7-
methyl-
2-
oxo-
1,2-
dihydro-
1,8-
naphthyridin-
3-
yl)propanoic acid
0
*Naphthyridines
Cyclic Nucleotide Phosphodiesterases, Type 4.
Int Immunopharmacol 2011 Jun;11(6):732-9
Genz-
644282
0
*Naphthyridines.
Clin Cancer Res. 2011 May 1;17(9):2777-87
PF 00217830
0
*Naphthyridines
*Piperazines.
Bioorg Med Chem Lett 2011 May 1;21(9):2621-5
9-
(6-
aminopyridin-
3-
yl)-
1-
(3-
(trifluoromethyl)phenyl)benzo(h)(1,6)naphthyridin-
2(1H)-
one
0
*Naphthyridines.
J Med Chem 2011 Mar 10;54(5):1473-80
CX 5461
0
*Naphthyridines
*Benzothiazoles
RNA Polymerase I/antagonists & inhibitors.
Cancer Res 2011 Feb 15;71(4):1418-30
1-
hydroxy-
1,8-
naphthyridin-
2(1H)-
one
0
*Naphthyridines.
Bioorg Med Chem Lett. 2010 Nov 15;20(22):6754-7
7-
(2-
methoxyethoxy)-
N-
((6-
(3-
methylisothiazol-
5-
yl)-
(1,2,4)triazolo(4,3-
b)pyridazin-
3-
yl)methyl)-
1,5-
naphthyridin-
4-
amine
0
*Naphthyridines
*Pyridazines.
Chem Res Toxicol 2010 Nov 15;23(11):1743-52
7-
methoxy-
N-
((6-
(3-
methylisothiazol-
5-
yl)-
(1,2,4)triazolo(4,3-
b)pyridazin-
3-
yl)methyl)-
1,5-
naphthyridin-
4-
amine
0
*Naphthyridines
*Pyridazines
Carbon Radioisotopes.
Chem Res Toxicol 2010 Nov 15;23(11):1743-52
5-
(3-
chlorophenylamino)benzo(c)(2,6)naphthyridine-
8-
carboxylic acid
0
*Naphthyridines
Casein Kinase II/antagonists & inhibitors.
Cancer Res 2010 Dec 15;70(24):10288-98
1-
(4-
(4-
propionylpiperazin-
1-
yl)-
3-
(trifluoromethyl)phenyl)-
9-
(quinolin-
3-
yl)benzo(h)(1,6)naphthyridin-
2(1H)-
one
0
*Naphthyridines.
J Med Chem 2010 Oct 14;53(19):7146-55
1,8-
naphthyridine-
pyrido(2,3-
b)pyrazine
0
*Naphthyridines
*Pyrazines.
Bioorg Med Chem Lett. 2010 Aug 1;20(15):4359-63
GSK966587
0
*Naphthyridines.
Org Lett. 2010 Aug 6;12(15):3422-5
4-
(2-
(4-
methoxybenzyl)perhydropyrido(3,2,1-
ij)(1,6)naphthyridin-
1-
yl)butanoic acid
0
*Naphthyridines.
Hepatology 2010 Sep;52(3):845-53
2,4,9-
trimethylbenzo(b)(1,8)naphthyridin-
5-
amine
0
*Naphthyridines.
J Pharmacol Exp Ther 2010 Sep 1;334(3):988-98
cyclohexyl-
(4-
(1-
piperazin-
1-
yl(2,6)naphthyridin-
3-
yl)pyridin-
2-
yl)amine
0
*Aminopyridines
*Naphthyridines.
J Med Chem 2010 Aug 12;53(15):5400-21
vinyl-
1,8-
naphthyridine
0
*Naphthyridines
*Vinyl Compounds.
Inorg Chem. 2010 May 17;49(10):4524-33
ethyl 5-
amino-
2-
methyl-
6,7,8,9-
tetrahydrobenzo(b)(1,8)naphthyridine-
3-
carboxylate
0
*Naphthyridines
Acetylcholinesterase.
Bioorg Med Chem Lett 2010 May 1;20(9):2950-3
1-
cyclopropyl-
5-
fluoro-
7-
(4-
(4-
formyl-
1H-
1,2,3-
triazol-
1-
yl)piperidin-
1-
yl)-
4-
oxo-
1,4-
dihydro-
1,8-
naphthyridine-
3-
carboxylic acid
0
*Naphthyridines.
Bioorg Med Chem Lett 2010 May 1;20(9):2859-63
7-
benzyl-
5-
(piperidin-
1-
yl)-
6,7,8,9-
tetrahydro-
3H-
pyrazolo(3,4-
c)(2,7)-
naphthyridin-
1-
ylamine
0
*Naphthyridines
*Pyrazoles
Receptors, Bombesin/agonists.
Bioorg Med Chem Lett 2010 May 1;20(9):2785-9
((3)H)-
1-
methyl-
5-
((N-
propylpiperidin-
4-
yl)methoxy)pyrrolo(1,2-
a)thieno(2,3-
e)pyrazinenzo(h)(1,6)naphthyridine
0
*Naphthyridines.
Eur J Med Chem. 2010 Mar;45(3):1263-5
((3)H)-
5-
((N-
propylpiperidin-
4-
yl)methoxy)-
1,2,3,4-
tetrahydrobenzo(h)(1,6) naphthyridine
0
*Naphthyridines
*Piperidines.
Eur J Med Chem. 2010 Mar;45(3):1263-5
7-
(3-
(trifluoromethyl)pyridin-
2-
yl)-
N-
(5-
(trifluoromethyl)pyridin-
2-
yl)-
1,8-
naphthyridin-
4-
amine
0
*Naphthyridines
TRPV Cation Channels/antagonists & inhibitors.
J Med Chem 2010 Apr 22;53(8):3330-48
N-
(3-
(1-
methylethyl)-
3-
((3-
(trifluoromethyl)-
7,8-
dihydro-
1,6-
naphthyridin-
6(5H)-
yl)carbonyl)cyclopentyl)tetrahydro-
2H-
pyran-
4-
amine
0
*Naphthyridines
Receptors, CCR2/antagonists & inhibitors.
Arterioscler Thromb Vasc Biol 2010 Feb;30(2):253-9
4-
(3-